IIC
BSX icon

Integrated Investment Consultants’s Boston Scientific BSX Stock Holding History

Integrated Investment Consultants’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-341
Closed -$9K – 236
2018
Q1 		$9K Buy
+341
New +$9.27K ﹤0.01% 641
2017
Q3 		$9K Buy
+300
New +$8.29K ﹤0.01% 523

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Integrated Investment Consultants's BSX Position: Q2 2018 in Review

Integrated Investment Consultants sold out of Boston Scientific (BSX) in Q2 2018, closing a stake of 341 shares — an estimated $9K sold.

Integrated Investment Consultants first reported a position in BSX in Q3 2017 and held it in 2 quarters. The position peaked at $9K in Q1 2018. 671 funds tracked by Wall St. Rank hold BSX as of Q2 2018.

  • Integrated Investment Consultants reported no remaining Boston Scientific position as of Q2 2018 after selling out during the quarter.
  • Integrated Investment Consultants sold 341 Boston Scientific shares in Q2 2018, an estimated $9K.
  • Integrated Investment Consultants first reported a position in Boston Scientific in Q3 2017 and held it in 2 quarters.
  • Integrated Investment Consultants's Boston Scientific position peaked at $9K in Q1 2018.
  • 671 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2018.

Based on Integrated Investment Consultants's 13F filing for Q2 2018, filed 1 Aug 2018.